Ligence Heart vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Ligence Heart

by Ligence

prolaio eVO2peak Module

by Prolaio

AI Verdict

Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography to enhance diagnostic efficiency and accuracy for various heart conditions. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption using data from wearable sensors for cardiovascular fitness assessment. While both are AI-powered tools for cardiology, they address distinct clinical needs and process different types of patient data.

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department seeks to automate and standardize the analysis and reporting of 2D transthoracic echocardiography. This platform is ideal for improving diagnostic efficiency and accuracy, streamlining workflows, and recognizing various cardiac diseases through automated measurements and report generation.

View Ligence Heart →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you need to non-invasively estimate peak oxygen consumption (eVO2peak) and assess functional capacity using real-world patient data from wearable medical sensors. This tool is particularly suited for longitudinal monitoring, cardiovascular research, and as an adjunctive aid in clinical evaluation where high-density activity and ECG data are valuable.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Ligence Heart	prolaio eVO2peak Module
Pricing	Contact-for-pricing	Unknown
Deployment	Cloud-based; on-premise; hybrid	Cloud
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart is designed as a web-based platform with an intuitive interface that automates complex echocardiography analysis and reporting, streamlining workflows for cardiologists and sonographers and reducing manual effort. In contrast, prolaio eVO2peak Module, while processing data from wearables, explicitly states it lacks a direct user interface, relying on integration with external systems for output display and interpretation by clinicians.

Clinical Value

Ligence Heart

Ligence Heart offers comprehensive diagnostic support by automating a broad range of echocardiography analyses, including disease recognition for heart failure, cardiomyopathy, and valvular heart diseases, directly enhancing diagnostic accuracy and efficiency. Prolaio eVO2peak Module provides a valuable, specific physiological metric (eVO2peak) from wearable data, validated for clinical evaluation, but its role is described as an 'adjunctive aid' rather than a comprehensive diagnostic tool.

Pricing & Value

Tie

Both Ligence Heart and prolaio eVO2peak Module utilize a 'contact for pricing' or 'enterprise quote' model, which is standard for specialized healthcare AI solutions. Without transparent pricing details or publicly available cost-benefit analyses for either product, it is not possible to definitively compare their value propositions.

Enterprise Readiness

Ligence Heart

Ligence Heart demonstrates stronger enterprise readiness with its flexible deployment options (cloud, on-premise, hybrid) and explicit integration capabilities with existing hospital systems like PACS, EHR, and RIS. While prolaio eVO2peak Module is FDA-cleared and cloud-based, its reliance on qualified third-party wearable medical sensors could introduce additional complexities for large-scale enterprise integration and management.

Innovation

Tie

Both tools showcase significant innovation. Ligence Heart innovates by automating and standardizing the complex and often variable process of echocardiography analysis and reporting, with studies indicating AI can surpass human performance in certain measurements. Prolaio eVO2peak Module innovates by leveraging real-world data from third-party wearable sensors to non-invasively estimate peak oxygen consumption, offering a novel approach to continuous cardiovascular functional assessment.

Support & Docs

Ligence Heart

Ligence Heart provides explicit customer service contact information and offers detailed user manuals in multiple languages, including specific versions for the USA market, indicating a comprehensive approach to documentation and user support. While prolaio eVO2peak Module mentions 'Always-on support' and integration documentation, the breadth and accessibility of its documentation are not as clearly articulated.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Ligence Heart	prolaio eVO2peak Module
Name	Ligence Heart	prolaio eVO2peak Module
Company	Ligence	Prolaio
Primary Function	Automates the analysis and reporting of 2D transthoracic echocardiography.	Estimates peak oxygen consumption (eVO2peak) using real-world patient data.
Input Data	2D transthoracic echocardiography imaging data, echocardiography images (PHI removed).	Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
Key Outputs/Results	Automated view classification, heart phase prediction, calculated measurements, generated reports, disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), automated strain, Spectral and Tissue Doppler measurements.	Estimated peak oxygen consumption (eVO2peak), information as an adjunctive aid in clinical evaluation, high-density, longitudinal data collection.

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers, including disease recognition for conditions like heart failure and valvular heart diseases. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care.

What types of patient data are required as input for each tool?

Ligence Heart requires 2D transthoracic echocardiography imaging data, with protected health information (PHI) removed, transferred from hospital PACS. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.

How do these tools integrate with existing clinical workflows and systems?

Ligence Heart explicitly integrates with existing systems such as PACS, EHR, and RIS, and handles the transfer of de-identified echocardiography images from hospital PACS. Prolaio eVO2peak Module processes remote sensor data from third-party wearables and provides information as an adjunctive aid, but specific integrations with PACS, EHR, or RIS are not detailed.

What specific measurements or insights does each tool provide?

Ligence Heart provides automated view classification, heart phase prediction, and quantification of Area, Distance, Doppler, Volume, Strain, Spectral, and Tissue Doppler measurements, along with disease recognition. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using a locked deep-learning model, enabling high-density, longitudinal data collection for clinical evaluation.